Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cardiovascular Intervention and Therapeutics
Published in: Cardiovascular Intervention and Therapeutics 2/2017

01-04-2017 | Case Report

A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy

Authors: Yuzo Kagawa, Nobuo Shiode, Tomoharu Kawase, Hiromichi Tamekiyo, Tomokazu Okimoto, Yasuhiko Hayashi

Published in: Cardiovascular Intervention and Therapeutics | Issue 2/2017

Login to get access

Abstract

This report describes a case of subacute stent thrombosis (SAT) after drug-coated balloon (DCB). A 79-year-old male was investigated for stable angina. An in-stent restenosis (ISR) lesion was detected by coronary angiography. A skin reaction related to the anti-platelet agent thienopyridine was also observed at this time. Therefore, DCB was used to treat the ISR lesion under single anti-platelet therapy (aspirin). However, 3 days after percutaneous coronary intervention, SAT occurred. OCT did not reveal the underlying cause of SAT. Further data are needed to clarify the optimal duration of dual anti-platelet therapy after DCB.
Literature
1.
Scheller B, Clever YP, Kelsch B, Hehrlein C, Bocksch W, et al. Long-term follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. JACC Cardiovasc Interv. 2012;5(3):323–30.CrossRefPubMed
2.
Rittger H, Brachmann J, Sinha AM, Waliszewski M, Ohlow M, et al. A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol. 2012;59(15):1377–82.CrossRefPubMed
3.
Habara S, Mitsudo K, Kadota K, Goto T, Fujii S, et al. Effectiveness of paclitaxel-eluting balloon catheter in patients with sirolimus-eluting stent restenosis. JACC Cardiovasc Interv. 2011;4(2):149–54.CrossRefPubMed
4.
Kolh P, Windecker S, Alfonso F, Collet JP, Cremer J, et al. 2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cariothorac Surg. 2014;46(4):517–92.CrossRef
5.
Joner M, Byrne RA, Lapointe JM, Radke PW, Bayer G, Steigerwald K, et al. Comparative assessment of drug-eluting balloons in an advanced porcine model of coronary restenosis. Thromb Haemost. 2011;105:864–72.CrossRefPubMed
6.
Gao S, Sheb J, Mukku VK, Wang MJ, Akhtar M, et al. Efficacy of drug-eluting balloons for patients with in-stent restenosis: a meta-analysis of 8 randomized controlled trials. Angiology. 2015;0003319715611826.
7.
Zeymer U, Waliszewski M, Spiecker M, Gastmann O, Faurie B, Ferrari M, et al. Prospective ‘real world’ registry for the use of the ‘PCB only’ strategy in small vessel de novo lesions. Heart. 2014;100:311–6.CrossRefPubMed
8.
Edouard C, Laurent L, Gary SM, Jun-ichi Augusto DP, Lowell FS, et al. Predictors of subacute stent thrombosis results of a systematic intravascular ultrasound study. Circulation. 2003;108:43–7.CrossRef
9.
Stähli BE, Camici GG, Steffel J, Akhmedov A, Shojaati K, et al. Paclitaxel enhances thrombin-induced endothelial tissue factor expression via c-Jun terminal NH2 kinase activation. Circ Res. 2006;99(2):149–55.CrossRefPubMed
10.
Zhang S, Sun C, Hu H, He Y, Yao Y et al. Effects of paclitaxel on the ability of aspirin and clopidogrel to inhibit platelet aggregation. Clin Appl Thromb Hemost. 2015;1076029615576740.
11.
Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet. 2013;381(9865):461–7.CrossRefPubMed
12.
Tannenbaum SH, Finko R, Cines DB. Antibody and immune complexes induce tissue factor production by human endothelial cells. J Immunol. 1986;137:1532–7.PubMed
Metadata
Title
A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy
Authors
Yuzo Kagawa
Nobuo Shiode
Tomoharu Kawase
Hiromichi Tamekiyo
Tomokazu Okimoto
Yasuhiko Hayashi
Publication date
01-04-2017
Publisher
Springer Japan
Published in
Cardiovascular Intervention and Therapeutics / Issue 2/2017
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-016-0386-0

Other articles of this Issue 2/2017

Cardiovascular Intervention and Therapeutics 2/2017 Go to the issue

Original Article

Impact of a single universal guiding catheter on door-to-balloon time in primary transradial coronary intervention for ST segment elevation myocardial infarction

Case Report

Transradial intervention for chronic total occlusion at the external iliac artery using a bidirectional approach through a single guiding catheter

Case Report

A case of percutaneous coronary intervention for treatment of iatrogenic chronic total occlusion of the left circumflex artery after mitral valve repair

Case Report

Usefulness of rotational atherectomy with optical frequency domain imaging guidance for severe calcified coronary lesions after Kawasaki disease

Case Report

Life- and limb-saving endovascular therapy in a patient with acute abdominal aortic occlusion

Case Report

Successful transfemoral aortic valve implantation through aortic stent graft after endovascular repair of abdominal aortic aneurysm

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits